1st Apr 2009 16:30
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
We hereby inform you that on 31 March 2009, the interest of David Smith, a person discharging managerial responsibilities, in AstraZeneca PLC Ordinary Shares of $0.25 each, changed as detailed below. The change in interest relates to the vesting of a previously announced award made in March 2006 under the AstraZeneca Performance Share Plan, whereby, following the application of performance measures specified at the time of grant, David Smith has now become beneficially entitled to a percentage of the shares originally awarded. In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed. In addition, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting.
|
Name |
Number of Shares Awarded |
Vesting Percentage |
Number of Shares Lapsed |
Number of Shares Vested |
Number of Shares Withheld |
Net Number of Shares |
|
David Smith |
14,231 |
89% |
1,565 |
12,666 |
5,194 |
7,472 |
The market price of AstraZeneca PLC Ordinary Shares of $0.25 each on 31 March 2009 was 2451 pence.
A C N Kemp
Company Secretary
1 April 2009
Related Shares:
Astrazeneca